Mithat Gönen

Active 2001–2026

Also published as
Mithat Gonen
431
Papers
92,531
Citations
156
h-index
413
i10-index

Citations

Citations per year for Mithat Gönen1920: 1 citations1939: 1 citations1967: 1 citations1980: 1 citations1984: 1 citations1991: 2 citations1992: 1 citations1993: 2 citations1997: 2 citations1998: 1 citations2000: 3 citations2001: 5 citations2002: 18 citations2003: 52 citations2004: 104 citations2005: 174 citations2006: 237 citations2007: 358 citations2008: 338 citations2009: 437 citations2010: 454 citations2011: 466 citations2012: 595 citations2013: 586 citations2014: 729 citations2015: 807 citations2016: 783 citations2017: 929 citations2018: 918 citations2019: 3,216 citations2020: 3,595 citations2021: 3,306 citations2022: 2,817 citations2023: 2,171 citations2024: 3,521 citations2025: 1,670 citations2026: 89 citations2027: 1 citations1921–1938: no citations, so these years are not shown1940–1966: no citations, so these years are not shown1968–1979: no citations, so these years are not shown1981–1983: no citations, so these years are not shown1985–1990: no citations, so these years are not shown1994–1996: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,343 citing papers, 27% of this breakdownChina: 5,459 citing papers, 14.2% of this breakdownUnited Kingdom: 2,139 citing papers, 5.6% of this breakdownGermany: 2,074 citing papers, 5.4% of this breakdownItaly: 1,958 citing papers, 5.1% of this breakdownNetherlands: 1,448 citing papers, 3.8% of this breakdownFrance: 1,423 citing papers, 3.7% of this breakdownCanada: 1,250 citing papers, 3.3% of this breakdownJapan: 1,205 citing papers, 3.1% of this breakdownAustralia: 871 citing papers, 2.3% of this breakdownSpain: 870 citing papers, 2.3% of this breakdownSwitzerland: 805 citing papers, 2.1% of this breakdown
0%27%Other 22.1%

Fields

  • Medicine75.6%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology3.9%
  • Computer Science1.8%
  • Engineering1.3%
  • Materials Science0.8%
  • Other2.6%

Topics

  • CAR-T cell therapy research5%
  • Hepatocellular Carcinoma Treatment and Prognosis3.3%
  • Pancreatic and Hepatic Oncology Research3.3%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.7%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Radiomics and Machine Learning in Medical Imaging2.1%
  • Other81%

Coauthors

All papers

Open in search
  1. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Kinh Gian, Andrew S. Epstein, Parisa Momtaz, Wungki Park, Ryan Sugarman, Anna M. Varghese, Elizabeth Won, Avni M. Desai, Alice C. Wei, Michael I. D’Angelica, T. Peter Kingham, Ira Mellman, Taha Merghoub, Jedd D. Wolchok, Uğur Şahin, Özlem Türeci, Benjamin D. Greenbaum, William R. Jarnagin, Jeffrey A. Drebin, Eileen M. O’Reilly, Vinod P. Balachandran - Nature 2023 cited by 1,350

  2. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kurt A. Schalper, Luis A. Díaz - New England Journal of Medicine 2022 cited by 1,542

  3. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 2,675

  4. Assessing the Performance of Prediction Models

    Authors: , , , , , , , - Epidemiology 2009 cited by 4,864

  5. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

    Authors: , , , , , , , , - Nature 2017 cited by 1,854

  6. Nomograms in oncology: more than meets the eye

    Authors: , , , - The Lancet Oncology 2015 cited by 3,458

  7. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  8. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 560

  9. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michel Sadelain, Renier J. Brentjens - Science Translational Medicine 2014 cited by 2,497

  10. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sacha Gnjatic, Christine A. Iacobuzio–Donahue, Jedd D. Wolchok, Ronald P. DeMatteo, Timothy A. Chan, Benjamin D. Greenbaum, Taha Merghoub, Steven D. Leach - Nature 2017 cited by 1,229

  11. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 924

  12. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

    Authors: , , , - BMC Medical Informatics and Decision Making, BMC Medical Informatics Decis. Mak. 2008 cited by 1,441

  13. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mithat Gönen, Luc G.T. Morris, Nils Weinhold, Timothy A. Chan - Nature Biotechnology 2021 cited by 270

  14. Concordance probability and discriminatory power in proportional hazards regression

    Authors: , - Biometrika 2005 cited by 677

  15. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth

    Authors: , , , , , , , , , , , , , , , , , - Nature Nanotechnology 2016 cited by 634

  16. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 594

  17. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185

  18. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

    Authors: , , , , , , - Nature Biotechnology 2013 cited by 468

  19. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 cited by 645

  20. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 341

  21. Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine - New England Journal of Medicine 2012 cited by 1,948

  22. RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wungki Park, Ryan Sugarman, Anna M. Varghese, Elizabeth Won, Avni M. Desai, Alice C. Wei, Michael I. D’Angelica, T. Peter Kingham, Kevin C. Soares, William R. Jarnagin, Jeffrey A. Drebin, Eileen M. O’Reilly, Ira Mellman, Uğur Şahin, Özlem Türeci, Benjamin D. Greenbaum, Vinod P. Balachandran - Nature 2025 cited by 232

  23. Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , - Annals of Surgery 2008 cited by 884

  24. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2012 cited by 808